Keyphrases
1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
12%
Caudate-putamen
12%
Clinical Model
25%
Differentially Expressed
25%
Dopamine
25%
Dopamine Transporter
12%
Dopaminergic Neurodegeneration
12%
Early Diagnosis
12%
Histological Analysis
12%
Hydrochloride
12%
Induced Loss
12%
MicroRNA
100%
MiR-124
12%
MiR-133b
12%
Motor Symptoms
12%
Mouse Model
100%
Neurodegenerative Diseases
12%
Neurotransmitters
12%
Next-generation Sequencing
12%
Parkinson's Disease
100%
Parkinson's Disease Model
100%
Potential Biomarkers
12%
Serum Levels
12%
Substantia Nigra Pars Compacta
50%
Tyrosine Hydroxylase
12%
Pharmacology, Toxicology and Pharmaceutical Science
1,2,3,6 Tetrahydro 1 Methyl 4 Phenylpyridine
54%
Biological Marker
27%
Degenerative Disease
9%
Disease
18%
Dopamine Receptor Stimulating Agent
18%
Dopamine Transporter
9%
microRNA
100%
Mitochondrial Permeability Transition Pore
45%
Mouse Model
100%
Nerve Degeneration
9%
Neurotransmitter
9%
Parkinson's Disease
100%
Tyrosine 3 Monooxygenase
9%
Neuroscience
Chloride
11%
Diagnosis of Parkinson's Disease
22%
Dopamine Transporter
11%
Dopaminergic
22%
MicroRNA
100%
Mitochondrial Permeability Transition Pore
55%
Neurodegeneration
11%
Neurodegenerative Disorder
11%
Neurotransmitter
11%
Parkinson's Disease
100%
Putamen
11%
Substantia Nigra Pars Compacta
44%
Tetrahydropyridine
11%
Tyrosine Hydroxylase
11%
Immunology and Microbiology
Blood Level
25%
Metabolite
25%
Mouse Model
100%
Next Generation Sequencing
25%
Putamen
25%
Substantia Nigra Pars Compacta
100%